Regulation of BACE1 by miR-29a/b in a cellular model of spinocerebellar ataxia 17

RNA Biology

Volumn 9, Issue 6, 2012, Pages 891-899

  Roshan, Reema ^a   Ghosh, Tanay ^a   Gadgil, Mugdha ^b   Pillai, Beena ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

BACE1; miR 29a b; Neurodegeneration; SCA17; TBP

Indexed keywords

BETA SECRETASE 1; CYTOCHROME C; MICRORNA 29A; MICRORNA 29B; POLYGLUTAMINE; PROTEIN BAK; PUMA PROTEIN; TATA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; MOLECULAR MODEL; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PURKINJE CELL; SPINOCEREBELLAR DEGENERATION; UPREGULATION;

EID: 84863483212     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.19876     Document Type: Article

References (48)

1. Cummings CJ, Zoghbi HY. Trinucleotide repeats: mechanisms and pathophysiology. Annu Rev Genomics Hum Genet 2000; 1:281-328; PMID:11701632; http://dx.doi.org/10.1146/annurev.genom.1.1.281.
2. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000; 23:217-47; PMID:10845064; http://dx.doi.org/10.1146/annurev. neuro.23.1.217.
3. Bauer PO, Nukina N. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem 2009; 110:1737-65; PMID:19650870; http://dx.doi.org/10.1111/j.1471-4159.2009.06302.x.
4. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 1999; 8:2047-53; PMID:10484774; http://dx.doi.org/10.1093/hmg/8.11.2047.
5. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001; 10:1441-8; PMID:11448935; http://dx.doi.org/10.1093/hmg/10.14.1441.
6. Mariotti C, Alpini D, Fancellu R, Soliveri P, Grisoli M, Ravaglia S, et al. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients. J Neurol 2007; 254:1538-46; PMID:17934876; http://dx.doi.org/10.1007/s00415-007-0579-7.
7. Zühlke C, Hellenbroich Y, Dalski A, Kononowa N, Hagenah J, Vieregge P, et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 2001; 9:160-4; PMID:11313753; http://dx.doi.org/10.1038/sj.ejhg.5200617.
8. Uchihara T, Fujigasaki H, Koyano S, Nakamura A, Yagishita S, Iwabuchi K. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias - triple-labeling immunofluorescence study. Acta Neuropathol 2001; 102:149-52; PMID:11563629.
9. van Roon-Mom WM, Reid SJ, Faull RL, Snell RG. TATA-binding protein in neurodegenerative disease. Neuroscience 2005; 133:863-72; PMID:15916858; http://dx.doi.org/10.1016/j.neuroscience.2005.03.024.
10. Hampsey M. Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev 1998; 62:465-503; PMID:9618449.
11. Friedman MJ, Shah AG, Fang ZH, Ward EG, Warren ST, Li S, et al. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci 2007; 10:1519-28; PMID:17994014; http://dx.doi.org/10.1038/nn2011.
12. Chang YC, Lin CY, Hsu CM, Lin HC, Chen YH, Lee-Chen GJ, et al. Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17. J Neurochem 2011; 118:288-303; PMID:21554323; http://dx.doi.org/10.1111/j.1471-4159.2011.07304.x.
13. Ghosh T, Pandey N, Maitra A, Brahmachari SK, Pillai B. A role for voltage-dependent anion channel Vdac1 in polyglutamine-mediated neuronal cell death. PLoS One 2007; 2:1170; PMID:18000542; http://dx.doi.org/10.1371/journal. pone.0001170.
14. Shah AG, Friedman MJ, Huang S, Roberts M, Li XJ, Li S. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17. Hum Mol Genet 2009; 18:4141-52; PMID:19643914; http://dx.doi.org/10.1093/hmg/ddp363.
15. Hébert SS, Horré K, Nicolaï L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105:6415-20; PMID:18434550; http://dx.doi.org/10.1073/pnas.0710263105.
16. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008; 29:438-45; PMID:18082412; http://dx.doi.org/10.1016/j.nbd.2007.11.001.
17. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317:1220-4; PMID:17761882; http://dx.doi.org/10.1126/science.1140481.
18. De Strooper B, Vassar R, Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 2010; 6:99-107; PMID:20139999; http://dx.doi.org/10.1038/nrneurol.2009.218.
19. Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 2005; 8:1343-9; PMID:16136043; http://dx.doi.org/10.1038/nn1531.
20. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 2004; 101:3632-7; PMID:14978286; http://dx.doi.org/10.1073/pnas.0205689101.
21. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 2007; 27:3639-49; PMID:17409228; http://dx.doi.org/10.1523/JNEUROSCI. 4396-06.2007.
22. Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One 2009; 4:8477; PMID:20041192; http://dx.doi.org/10.1371/journal.pone.0008477.
23. Lichtenthaler SF, Dominguez DI, Westmeyer GG, Reiss K, Haass C, Saftig P, et al. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem 2003; 278:48713-9; PMID:14507929; http://dx.doi.org/10.1074/jbc.M303861200.
24. von Arnim CA, Kinoshita A, Peltan ID, Tangredi MM, Herl L, Lee BM, et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem 2005; 280:17777-85; PMID:15749709; http://dx.doi.org/10.1074/jbc.M414248200.
25. Wong HK, Sakurai T, Oyama F, Kaneko K, Wada K, Miyazaki H, et al. beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J Biol Chem 2005; 280:23009-17; PMID:15824102; http://dx.doi.org/10.1074/jbc. M414648200.
26. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM, et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci USA 2004; 101:360-5; PMID:14691248; http://dx.doi.org/10.1073/pnas.2333854100.
27. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129:1401-14; PMID:17604727; http://dx.doi.org/10.1016/j.cell.2007.04.040.
28. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008; 5:117; PMID:19102781; http://dx.doi.org/10.1186/1742-4690-5-117.
29. Kole AJ, Swahari V, Hammond SM, Deshmukh M. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev 2011; 25:125-30; PMID:21245165; http://dx.doi.org/10.1101/gad.1975411.
30. Eacker SM, Dawson TM, Dawson VL. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 2009; 10:837-41; PMID:19904280.
31. Roshan R, Ghosh T, Scaria V, Pillai B. MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today 2009; 14:1123-9; PMID:19822222; http://dx.doi.org/10.1016/j.drudis.2009.09.009.
32. Weinberg MS, Wood MJ. Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum Mol Genet 2009; 18:27-39; PMID:19297399; http://dx.doi.org/10.1093/hmg/ddp070.
33. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008; 11:1137-9; PMID:18758459; http://dx.doi.org/10. 1038/nn.2183.
34. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 2006; 24:157-63; PMID:17018300; http://dx.doi.org/10.1016/j.molcel.2006.07.030.
35. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. A miRNA signature of prion induced neurodegeneration. PLoS One 2008; 3:3652; PMID:18987751; http://dx.doi.org/10.1371/journal.pone.0003652.
36. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008; 28:1213-23; PMID:18234899; http://dx.doi.org/10.1523/JNEUROSCI.5065-07.2008.
37. Jadhav VM, Scaria V, Maiti S. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function. Angew Chem Int Ed Engl 2009; 48:2557-60; PMID:19229913; http://dx.doi.org/10.1002/anie.200805521.
38. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455:58-63; PMID:18668040; http://dx.doi.org/10.1038/nature07228.
39. Kumar P, Lee SK, Shankar P, Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 2006; 3:96; PMID:16464133; http://dx.doi.org/10.1371/journal.pmed.0030096.
40. Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010; 11:56; PMID:20507594; http://dx.doi.org/10.1186/gb- 2010-11-5-r56.
41. Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 2009; 284:1971-81; PMID:18986979; http://dx.doi.org/10.1074/jbc.M807530200.
42. Huth T, Schmidt-Neuenfeldt K, Rittger A, Saftig P, Reiss K, Alzheimer C. Non-proteolytic effect of beta-site APP-cleaving enzyme 1 (BACE1) on sodium channel function. Neurobiol Dis 2009; 33:282-9; PMID:19056495; http://dx.doi.org/10.1016/j.nbd.2008.10.015.
43. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, et al. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 2007; 9:755-64; PMID:17576410; http://dx.doi.org/10.1038/ncb1602.
44. Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci 2008; 28:11768-77; PMID:19005038; http://dx.doi.org/10.1523/JNEUROSCI.3901-08.2008.
45. Kalume F, Yu FH, Westenbroek RE, Scheuer T, Catterall WA. Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 2007; 27:11065-74; PMID:17928448; http://dx.doi.org/10.1523/JNEUROSCI.2162-07.2007.
46. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45.
47. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39:152-7; PMID:21037258; http://dx.doi.org/10.1093/nar/gkq1027.
48. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12:996-1006; PMID:12045153.